Alnylam Pharmaceuticals
ALNY
#786
Rank
ยฃ23.93 B
Marketcap
ยฃ178.86
Share price
-2.42%
Change (1 day)
-46.70%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company